Tagged with Drug Pricing

Gilead CEO Named New PhRMA Board Chair; Inherits a Litany of Challenges
Merck’s IRA Lawsuit Comes Under Fire from Own Shareholders
AbbVie Withdraws from PhRMA & BIO after US Drug Pricing Defeat
Interview: Kateřina Podrazilová – Chair of the Pharmaceutical Committee, Association of Health Insurance Companies, Czech Republic
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here